Drag a card by its title · ⚙ to size, swap or remove

The company

Syntec Optics Holdings, Inc.

OPTX · Nasdaq

Health CareLife-science toolsNot moving yetDefense-Tech

OPTX stood above a rising 150-day average in 37 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 25.4% below that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 2
Industry in uptrend: 52% +4 in 4 wk
Insider buys, 12 months: $160K
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 61 (+23)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 37 of 52 weeks.

17 Apr – 16 Oct

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2

Sale orders, 12 months0

Buyers · sellers1 · 0

Who	Did	Shares	Traded
Albert ManzoneDirector	bought	3,681at $8.12	19 Aug 2026filed 26 Aug 2026
Albert ManzoneDirector	bought	5,000at $10.00	14 Apr 2026filed 26 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders61+23 on the quarter

New · exited34 · 11

Reported value$60.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Arete Wealth Advisors, LLCnew · filed 11 Aug 2026	1,896,970$23.6M	+1,896,970
Tema ETFs LLCnew · filed 10 Jul 2026	615,400$7.7M	+615,400
Tidal Investments LLCnew · filed 13 Aug 2026	613,879$7.6M	+613,879
BlackRock, Inc.added · filed 7 Aug 2026	427,641$5.3M	+387,849+974.7%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	211,241$2.6M	+120,195+132.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	105,826$1.3M	+37,114+54.0%
ROYAL BANK OF CANADAadded · filed 14 Aug 2026	88,752$1.1M	+15,404+21.0%
STATE STREET CORPadded · filed 7 Aug 2026	86,250$1.1M	+61,850+253.5%
VANGUARD PORTFOLIO MANAGEMENT LLCnew · filed 13 Aug 2026	76,675$955K	+76,675
DNB Asset Management ASreduced · filed 11 Aug 2026	69,452$865K	-146,505−67.8%

31 Dec 2023 – 30 Jun 2026

News

No headline names it lately.

Everyone who traded it

Alok Kapoor Chairman & CEO · last 18 Sep 20260 · 0

Albert Manzone Director · last 19 Aug 20262 · 0

Brent D. Rosenthal Director · last 20 Feb 20260 · 0

Walter A. Bishop Director · last 20 Feb 20260 · 0

Omnilit Sponsor, Llc 10% owner · last 3 Apr 20230 · 0

GOLDMAN SACHS GROUP INC 10% owner · last 19 Jan 20230 · 0

Same industry

OABI OmniAbLeading+65%

TXG 10x GenomicsLeading+60%

AVTR AvantorLeading+47%

ILMN IlluminaLeading+44%

RVTY RevvityLeading+37%

CRL Charles River Laboratories InternationalLeading+35%

MASS 908 DevicesLeading+31%

IQV IQVIA HoldingsLeading+27%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202523.3%

Operating profit marginFY 2025 · to 31 Dec 2025-1.8%

Free cash flow marginFY 2025 · to 31 Dec 20250.1%

Return on capital employedFY 2025 · to 31 Dec 2025-4.0%

Debt to equityFY 2025 · to 31 Dec 20250.33×

Research spendFY 2025 · to 31 Dec 20252.1%

Share count trendFY 2025 · to 27 Mar 20260.2%

Free cash flowFY 2025 · to 31 Dec 2025$28K

Analyst forecasts

No analyst forecasts yet.